The SEMA Show is the premier destination for manufacturers and buyers looking to discover thousands of the latest innovations in the automotive aftermarket industry. Spanning four days, this trade-only event encourages attendees to experience hands-on workshops and live demonstrations, engage in educational seminars and network with peers in various sectors of the field—from collision repair to vehicle restoration and more.
More stories
Battery Electric Vehicle Collision Claims Continue to Rise Despite Sales Slowdown
August 15, 2024
Mitchell today published its Q2 2024 Plugged-In: EV Collision Insights report. This edition features the latest U.S. and Canadian claims data on battery electric vehicles (BEVs), mild hybrid electric vehicles (MHEVs) and plug-in hybrid electric vehicles (PHEVs)—highlighting how differences in their complexity and construction are affecting claim costs and repair operations.
Plugged-In: EV Collision Insights Q2 2024
August 15, 2024
Claims frequency for repairable, collision-damaged battery electric vehicles (BEVs) rose to 2.5% in the U.S. and 3.94% in Canada in Q2 2024—a year-over-year increase of 45% and 39% respectively. According to the Alliance for Automotive Innovation, EVs represented 9.3% of new U.S. light-duty vehicle sales in Q1 2024, down from 10.2% in Q4 2023. Similarly, in Canada BEV sales fell to 9.2% last quarter, down from 10% in Q4 2023.
Bridging the Gap for New Adjusters with Innovative Tools
August 13, 2024
Streamline your claims process and support your team with our cutting-edge solutions.
New Trends in Opioids and Pain Management
August 7, 2024
Despite decreases in utilization and cost per claim, opioids remain the No. 1 drug class in Enlyte’s 2024 Drug Trends Report. However, due to concerns with safety and overutilization, increased focus on usage guidelines as well as alternatives to pain management are gaining momentum — including those whose active ingredients drive from things you might not imagine, like pufferfish, cacti and chili peppers. Enlyte’s Nikki Wilson explores this and more in our Part 3 drug trends analysis.
Ask The Pharmacist: GLP-1 Drugs in Workers’ Compensation
August 6, 2024
Glucagon-like peptide 1 (GLP-1) receptor agonists medications, originally designed for diabetes management, have skyrocketed in popularity over the past year as effective drugs for weight loss and obesity.
Current Used Vehicle Market Conditions: Q2 2024
July 29, 2024
Wholesale prices fell for the second consecutive month in May and continued to fall into mid-June, as the less-than-impressive 2024 Spring/tax season market came to an early close. Nevertheless, wholesale and retail used vehicle market conditions are amenable to a less dramatic ongoing decline in prices than seen last year, as much of the correction to historical patterns of depreciation, seasonality and price-spread versus new vehicles has already taken place.